Literature DB >> 30504819

Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.

Emine M Onal1, Baris Afsar2, Adrian Covic3, Nosratola D Vaziri4, Mehmet Kanbay5.   

Abstract

The health and proper functioning of the cardiovascular and renal systems largely depend on crosstalk in the gut-kidney-heart/vessel triangle. Recent evidence suggests that the gut microbiota has an integral function in this crosstalk. Mounting evidence indicates that the development of chronic kidney and cardiovascular diseases follows chronic inflammatory processes that are affected by the gut microbiota via various immune, metabolic, endocrine, and neurologic pathways. Additionally, deterioration of the function of the cardiovascular and renal systems has been reported to disrupt the original gut microbiota composition, further contributing to the advancement of chronic cardiovascular and renal diseases. Considering the interaction between the gut microbiota and the renal and cardiovascular systems, we can infer that interventions for the gut microbiota through diet and possibly some medications can prevent/stop the vicious cycle between the gut microbiota and the cardiovascular/renal systems, leading to a decrease in chronic cardiovascular and renal diseases.

Entities:  

Keywords:  Cardiovascular disease; Chronic kidney disease; Gut microbiota; Uremic toxins

Mesh:

Year:  2018        PMID: 30504819     DOI: 10.1038/s41440-018-0144-z

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  24 in total

Review 1.  Role of the microbiota in hypertension and antihypertensive drug metabolism.

Authors:  Eikan Mishima; Takaaki Abe
Journal:  Hypertens Res       Date:  2021-12-09       Impact factor: 3.872

Review 2.  The Use of Healthy Eating Index 2015 and Healthy Beverage Index for Predicting and Modifying Cardiovascular and Renal Outcomes.

Authors:  Lale A Ertuglu; Atalay Demiray; Baris Afsar; Alberto Ortiz; Mehmet Kanbay
Journal:  Curr Nutr Rep       Date:  2022-04-27

Review 3.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

4.  Flow Cytometry of CD14, VDR, Cyp27 and Cyp24 and TLR4 in U937 Cells.

Authors:  Jacqueline Ferritto Rebello; Rodrigo Barbosa de Oliveira Brito; Caren Cristina Grabulosa; Rosa Maria Affonso Moyses; Rosilene Motta Elias; Maria Aparecida Dalboni
Journal:  Bio Protoc       Date:  2020-08-05

5.  Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.

Authors:  Lingxiong Chai; Qun Luo; Kedan Cai; Kaiyue Wang; Binbin Xu
Journal:  BMC Nephrol       Date:  2021-06-03       Impact factor: 2.388

6.  Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment.

Authors:  Yinghui Huang; Jie Zhou; Shaobo Wang; Jiachuan Xiong; Yin Chen; Yong Liu; Tangli Xiao; Yi Li; Ting He; Yan Li; Xianjin Bi; Ke Yang; Wenhao Han; Yu Qiao; Yanli Yu; Jinghong Zhao
Journal:  Theranostics       Date:  2020-06-05       Impact factor: 11.556

Review 7.  Hypertension as a Metabolic Disorder and the Novel Role of the Gut.

Authors:  Masami Tanaka; Hiroshi Itoh
Journal:  Curr Hypertens Rep       Date:  2019-06-24       Impact factor: 5.369

8.  25-vitamin D reduces inflammation in uremic environment.

Authors:  Rodrigo Barbosa de Oliveira Brito; Jacqueline Ferritto Rebello; Caren Cristina Grabulosa; Walter Pinto; Armando Morales; Rosilene Motta Elias; Rosa Maria Affonso Moyses; Maria Aparecida Dalboni
Journal:  Sci Rep       Date:  2020-01-10       Impact factor: 4.379

9.  Multi-Solvent Extraction Procedure for the Pioneer Fecal Metabolomic Analysis-Identification of Potential Biomarkers in Stable Kidney Transplant Patients.

Authors:  Soumaya Kouidhi; Nessrine Souai; Muhanad Alhujaily; Oumaima Zidi; Ameni Kochbati; Alaeddine Redissi; Tareg M Belali; Imene El Kossai; Jamelddine El Manaa; Ameur Cherif; Wissem Mnif; Amor Mosbah
Journal:  Diagnostics (Basel)       Date:  2021-05-26

Review 10.  The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.

Authors:  Marius Trøseid; Geir Øystein Andersen; Kaspar Broch; Johannes Roksund Hov
Journal:  EBioMedicine       Date:  2020-02-12       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.